FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
DIDRONEL
etidronate disodium
LOE Approaching
INJECTION · INJECTABLE
1987
NDA30/100
DIDRONEL
etidronate disodium
LOE Approaching
ORAL · TABLET
1977
NDA30/100
DIENESTROL
dienestrol
LOE Approaching
Johnson & Johnson
VAGINAL · CREAM
1947
NDA30/100
DIFFERIN
adapalene
LOE Approaching
Galderma
TOPICAL · CREAM
2000
NDA30/100
DIFFERIN
adapalene
LOE Approaching
Galderma
TOPICAL · GEL
1996
NDA30/100
DIFFERIN
adapalene
LOE Approaching
Galderma
TOPICAL · GEL
2007
NDA30/100
DIFFERIN
adapalene
LOE Approaching
Galderma
TOPICAL · SOLUTION
1996
NDA30/100
DIFLUCAN
fluconazole
LOE Approaching
Pfizer
ORAL · TABLET
1990
SMNDA30/100
DIFLUCAN
fluconazole
LOE Approaching
Pfizer
ORAL · FOR SUSPENSION
1993
SMNDA30/100
DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER
fluconazole
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1990
SMNDA30/100
DIFLUCAN IN SODIUM CHLORIDE 0.9%
fluconazole
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1990
SMNDA30/100
DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
fluconazole
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1990
SMNDA30/100
DILACOR XR
diltiazem hydrochloride
LOE Approaching
AbbVie
ORAL · CAPSULE, EXTENDED RELEASE
hypertensionchronic stable angina+1
1992
NDA30/100
DILANTIN
phenytoin sodium
LOE Approaching
Pfizer
INJECTION · INJECTABLE
generalized tonic-clonic (grand mal)complex partial (psychomotor+4
1956
NDA30/100
DILANTIN-125
phenytoin
LOE Approaching
Viatris (2)
ORAL · SUSPENSION
tonic-clonic (grand mal)psychomotor (temporal lobe) seizures
1953
NDA30/100
DILANTIN-30
phenytoin
LOE Approaching
Viatris (2)
ORAL · SUSPENSION
tonic-clonic (grand mal)psychomotor (temporal lobe) seizures
1953
NDA30/100
DILATRATE-SR
isosorbide dinitrate
LOE Approaching
ORAL · CAPSULE, EXTENDED RELEASE
angina pectoris due to coronary artery disease
1988
NDA30/100
DILAUDID
hydromorphone hydrochloride
LOE Approaching
ORAL · TABLET
pain severe enough to require an opioid analgesicfor which alternative treatments are inadequate
1992
NDA30/100
DILAUDID
hydromorphone hydrochloride
LOE Approaching
ORAL · SOLUTION
pain severe enough to require an opioid analgesicfor which alternative treatments are inadequate
1992
NDA30/100
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
LOE Approaching
ORAL · CAPSULE, EXTENDED RELEASE
hypertensionchronic stable angina+1
2000
NDA30/100
DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE
diltiazem hydrochloride
Growth
R-Pharm US
INTRAVENOUS · SOLUTION
atrial flutteratrial fibrillation
2025
NDA30/100
DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%
diltiazem hydrochloride
Peak
INTRAVENOUS · SOLUTION
hypertensionchronic stable angina+1
2021
NDA30/100
DIMETANE
brompheniramine maleate
LOE Approaching
Pfizer
ORAL · TABLET, EXTENDED RELEASE
these symptoms due to hay feverother upper respiratory allergies: runny nose sneezing itchy+2
1957
NDA30/100
DIMETANE-DX
brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride
LOE Approaching
ORAL · SYRUP
nasal congestion due to the common coldhay fever+3
1984
NDA30/100